Certified by Founder
Lodge
Santa Ana Bio, Inc.
start up
United States
- Alameda, California
- 14/06/2024
- Series A
- $168,000,000
Santa Ana Bio is a Bay Area biotech focused on leveraging it’s multiomics and protein engineering platforms to design precision biologics for the treatment of patients with serious immune related diseases.
- Industry Biotechnology Research
- Website https://www.santaanabio.com/
- LinkedIn https://www.linkedin.com/company/santaanabio/
Talvy | $2,000,000 | (Mar 11, 2026)
Unreasonable Labs | $13,500,000 | (Mar 11, 2026)
Sigma360 | $17,000,000 | (Mar 11, 2026)
R2 Wireless | $5,000,000 | (Mar 11, 2026)
Verdant Impact | $3,000,000 | (Mar 11, 2026)
Imperium Technologies, Inc | $2,000,000 | (Mar 11, 2026)
Lux Aeterna | $10,000,000 | (Mar 11, 2026)
Amigo | $11,000,000 | (Mar 11, 2026)
Axiom Trust Company | $11,800,000 | (Mar 11, 2026)
Sandbar | $23,000,000 | (Mar 11, 2026)
Jazz | $61,000,000 | (Mar 11, 2026)
PactFi | $25,000,000 | (Mar 11, 2026)